Sex differences in stroke

Cerebrovascular Diseases

Volumn 26, Issue 5, 2008, Pages 462-474

  Turtzo, L Christine ^a   McCullough, Louise D ^a  

^a UNIVERSITY OF CONNECTICUT HEALTH CENTER   (United States)

Author keywords

Cerebral ischemia; Hormones; Stroke; Stroke, gender

Indexed keywords

FEMALE; HUMAN; MALE; PATHOPHYSIOLOGY; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SECONDARY PREVENTION; SEX DIFFERENCE; STROKE;

ACUTE DISEASE; AGE FACTORS; ANIMALS; ASPIRIN; ATRIAL FIBRILLATION; CAROTID STENOSIS; CEREBROVASCULAR CIRCULATION; DISEASE MODELS, ANIMAL; ENDARTERECTOMY, CAROTID; FEMALE; GONADAL STEROID HORMONES; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOXIA-ISCHEMIA, BRAIN; MALE; PLATELET AGGREGATION INHIBITORS; POSTPARTUM PERIOD; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RECEPTORS, ESTROGEN; RECURRENCE; RISK FACTORS; SECONDARY PREVENTION; SEX FACTORS; STROKE; TREATMENT OUTCOME;

EID: 52049127043     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000155983     Document Type: Review

References (124)

1. Mackay J, Mensah G: The Atlas of Heart Disease and Stroke. Geneva, World Health Organization, 2004.
2. Rosamond W, Flegal K, Friday G, Furie K, Go A, Greenlund K, Haase N, Ho M, Howard V, Kissela B, Kittner S, Lloyd-Jones D, Mc-Dermott M, Meigs J, Moy C, Nichol G, O'Donnell CJ, Roger V, Rumsfeld J, Sorlie P, Steinberger J, Thom T, Wasserthiel-Smoller S, Hong Y: Heart disease and stroke statistics - 2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2007; 115:e69-e171.
3. Niewada M, Kobayashi A, Sandercock PA, Kaminski B, Czlonkowska A: Influence of gender on baseline features and clinical outcomes among 17,370 patients with confirmed ischaemic stroke in the international stroke trial. Neuroepidemiology 2005; 24: 123-128.
4. Roquer J, Campello AR, Gomis M: Sex differences in first-ever acute stroke. Stroke 2003; 34: 1581-1585.
5. Holroyd-Leduc JM, Kapral MK, Austin PC, Tu JV: Sex differences and similarities in the management and outcome of stroke patients. Stroke 2000; 31: 1833-1837.
6. Kapral MK, Fang J, Hill MD, Silver F, Richards J, Jaigobin C, Cheung AM: Sex differences in stroke care and outcomes: results from the Registry of the Canadian Stroke Network. Stroke 2005; 36: 809-814.
7. Di Carlo A, Lamassa M, Baldereschi M, Pracucci G, Basile AM, Wolfe CD, Giroud M, Rudd A, Ghetti A, Inzitari D: Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry. Stroke 2003; 34: 1114-1119.
8. Eriksson M, Norrving B, Terent A, Stegmayr B: Functional outcome 3 months after stroke predicts long-term survival. Cerebrovasc Dis 2008; 25: 423-429.
9. Kimura K, Minematsu K, Kazui S, Yamaguchi T: Mortality and cause of death after hospital discharge in 10,981 patients with ischemic stroke and transient ischemic attack. Cerebrovasc Dis 2005; 19: 171-178.
10. Pekmezovic T, Tepavcevic DK, Jarebinski M, Kostic M, Bumbasirevic L: Trends in mortality from different subtypes of stroke in the population of Belgrade (Serbia). Clin Neurol Neurosurg 2008; 110: 51-57.
11. Devroey D, Van Casteren V, Buntinx F: Registration of stroke through the Belgian Sentinel Network and factors influencing stroke mortality. Cerebrovasc Dis 2003; 16: 272-279.
12. Reid JM, Dai D, Gubitz GJ, Kapral MK, Christian C, Phillips SJ: Gender differences in stroke examined in a 10-year cohort of patients admitted to a Canadian teaching hospital. Stroke 2008; 39: 1090-1095.
13. Glader EL, Stegmayr B, Norrving B, Terent A, Hulter-Asberg K, Wester PO, Asplund K: Sex differences in management and outcome after stroke: a Swedish national perspective. Stroke 2003; 34: 1970-1975.
14. Gargano JW, Reeves MJ: Sex differences in stroke recovery and stroke-specific quality of life: results from a statewide stroke registry. Stroke 2007; 38: 2541-2548.
15. Eriksson M, Asplund K, Glader EL, Norrving B, Stegmayr B, Terent A, Asberg KH, Wester PO: Self-reported depression and use of antidepressants after stroke: a national survey. Stroke 2004; 35: 936-941.
16. Everson SA, Roberts RE, Goldberg DE, Kaplan GA: Depressive symptoms and increased risk of stroke mortality over a 29-year period. Arch Intern Med 1998; 158: 1133-1138.
17. House A, Knapp P, Bamford J, Vail A: Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001; 32: 696-701.
18. Herrmann N, Black SE, Lawrence J, Szekely C, Szalai JP: The Sunnybrook Stroke Study: a prospective study of depressive symptoms and functional outcome. Stroke 1998; 29: 618-624.
19. Parikh RM, Robinson RG, Lipsey JR, Starkstein SE, Fedoroff JP, Price TR: The impact of poststroke depression on recovery in activities of daily living over a 2-year follow-up. Arch Neurol 1990; 47: 785-789.
20. Foerch C, Misselwitz B, Humpich M, Steinmetz H, Neumann-Haefelin T, Sitzer M: Sex disparity in the access of elderly patients to acute stroke care. Stroke 2007; 38: 2123-2126.
21. Lisabeth LD, Brown DL, Morgenstern LB: Barriers to intravenous tissue plasminogen activator for acute stroke therapy in women. Gend Med 2006; 3: 270-278.
22. Reed SD, Cramer SC, Blough DK, Meyer K, Jarvik JG: Treatment with tissue plasminogen activator and inpatient mortality rates for patients with ischemic stroke treated in community hospitals. Stroke 2001; 32: 1832-1840.
23. Gargano JW, Wehner S, Reeves M: Sex differences in acute stroke care in a statewide stroke registry. Stroke 2008; 39: 24-29.
24. Savitz SI, Schlaug G, Caplan L, Selim M: Arterial occlusive lesions recanalize more frequently in women than in men after intravenous tissue plasminogen activator administration for acute stroke. Stroke 2005; 36: 1447-1451.
25. Kent DM, Price LL, Ringleb P, Hill MD, Selker HP: Sex-based differences in response to recombinant tissue plasminogen activator in acute ischemic stroke: a pooled analysis of randomized clinical trials. Stroke 2005; 36: 62-65.
26. Saposnik G, Di Legge S, Webster F, Hachinski V: Predictors of major neurologic improvement after thrombolysis in acute stroke. Neurology 2005; 65: 1169-1174.
27. Elkind MS, Prabhakaran S, Pittman J, Koroshetz W, Jacoby M, Johnston KC: Sex as a predictor of outcomes in patients treated with thrombolysis for acute stroke. Neurology 2007; 68: 842-848.
28. Hill MD, Kent DM, Hinchey J, Rowley H, Buchan AM, Wechsler LR, Higashida RT, Fischbein NJ, Dillon WP, Gent M, Firszt CM, Schulz GA, Furlan AJ: Sex-based differences in the effect of intra-arterial treatment of stroke: analysis of the PROACT-2 study. Stroke 2006; 37: 2322-2325.
29. Kent DM, Buchan AM, Hill MD: The gender effect in stroke thrombolysis. Of CASES, controls, and treatment-effect modification. Neurology 2008, E-pub ahead of print.
30. Labiche LA, Chan W, Saldin KR, Morgenstern LB: Sex and acute stroke presentation. Ann Emerg Med 2002; 40: 453-460.
31. Meischke H, Larsen MP, Eisenberg MS: Gender differences in reported symptoms for acute myocardial infarction: impact on prehospital delay time interval. Am J Emerg Med 1998; 16: 363-366.
32. Smith MA, Lisabeth LD, Brown DL, Morgenstern LB: Gender comparisons of diagnostic evaluation for ischemic stroke patients. Neurology 2005; 65: 855-858.
33. Wolf PA, Abbott RD, Kannel WB: Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983-988.
34. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB: Impact of atrial fibrillation on mortality, stroke, and medical costs. Arch Intern Med 1998; 158: 229-234.
35. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS: Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (atria) study. Circulation 2005; 112: 1687-1691.
36. Ridker PM, Cook NR, Lee IM, Gordon D, Gaziano JM, Manson JE, Hennekens CH, Buring JE: A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women. N Engl J Med 2005; 352: 1293-1304.
37. Final report on the aspirin component of the ongoing Physicians' Health Study. Steering Committee of the Physicians' Health Study Research Group. N Engl J Med 1989; 321: 129-135.
38. Berger JS, Roncaglioni MC, Avanzini F, Pangrazzi I, Tognoni G, Brown DL: Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 2006; 295: 306-313.
39. Simpson CR, Wilson C, Hannaford PC, Williams D: Evidence for age and sex differences in the secondary prevention of stroke in Scottish primary care. Stroke 2005; 36: 1771-1775.
40. Müller-Nordhorn J, Nolte CH, Rossnagel K, Jungehülsing GJ, Reich A, Roll S, Villringer A, Willich SN: Medical management in patients following stroke and transitory ischemic attack: a comparison between men and women. Cerebrovasc Dis 2006; 21: 329-335.
41. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Hypertension 2003; 42: 1206-1252.
42. North American Symptomatic Carotid Endarterectomy Trial Collaborators: Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med 1991; 325: 445-453.
43. Chaturvedi S, Bruno A, Feasby T, Holloway R, Benavente O, Cohen SN, Cote R, Hess D, Saver J, Spence JD, Stern B, Wilterdink J: Carotid endarterectomy - an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 2005; 65: 794-801.
44. Rothwell PM, Slattery J, Warlow CP: Clinical and angiographic predictors of stroke and death from carotid endarterectomy: systematic review. BMJ 1997; 315: 1571-1577.
45. Bond R, Rerkasem K, Cuffe R, Rothwell PM: A systematic review of the associations between age and sex and the operative risks of carotid endarterectomy. Cerebrovasc Dis 2005; 20: 69-77.
46. Kapral MK, Wang H, Austin PC, Fang J, Kucey D, Bowyer B, Tu JV: Sex differences in carotid endarterectomy outcomes: Results from the Ontario Carotid Endarterectomy Registry. Stroke 2003; 34: 1120-1125.
47. Barnett HJ, Taylor DW, Eliasziw M, Fox AJ, Ferguson GG, Haynes RB, Rankin RN, Clagett GP, Hachinski VC, Sackett DL, Thorpe KE, Meldrum HE, Spence JD: Benefit of carotid endarterectomy in patients with symptomatic moderate or severe stenosis. North American Symptomatic Carotid Endarterectomy Trial Collaborators. N Engl J Med 1998; 339: 1415-1425.
48. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ: Endarterectomy for symptomatic carotid stenosis in relation to clinical subgroups and timing of surgery. Lancet 2004; 363: 915-924.
49. Rothwell PM, Goldstein LB: Carotid endarterectomy for asymptomatic carotid stenosis: asymptomatic carotid surgery trial. Stroke 2004; 35: 2425-2427.
50. Dick P, Sherif C, Sabeti S, Amighi J, Minar E, Schillinger M: Gender differences in outcome of conservatively treated patients with asymptomatic high grade carotid stenosis. Stroke 2005; 36: 1178-1183.
51. Rothwell PM, Eliasziw M, Gutnikov SA, Warlow CP, Barnett HJ: Sex difference in the effect of time from symptoms to surgery on benefit from carotid endarterectomy for transient ischemic attack and nondisabling stroke. Stroke 2004; 35: 2855-2861.
52. Paganini-Hill A: Hormone replacement therapy and stroke: risk, protection or no effect? Maturitas 2001; 38: 243-261.
53. Langer RD: Hormone replacement and the prevention of cardiovascular disease. Am J Cardiol 2002; 89: 36E-46E.
54. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/Progestin Replacement Study (HERS) research group. JAMA 1998; 280: 605-613.
55. Viscoli CM, Brass LM, Kernan WN, Sarrel PM, Suissa S, Horwitz RI: A clinical trial of estrogen-replacement therapy after ischemic stroke. N Engl J Med 2001; 345: 1243-1249.
56. Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW: Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: analysis of 2,012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999; 30: 1223-1229.
57. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb JD, Black H, Rossouw JE, Aragaki A, Safford M, Stein E, Laowattana S, Mysiw WJ: Effect of estrogen plus progestin on stroke in postmenopausal women: the women's health initiative: a randomized trial. JAMA 2003; 289: 2673-2684.
58. Bushnell CD: Oestrogen and stroke in women: assessment of risk. Lancet Neurol 2005; 4: 743-751.
59. Simpkins JW, Rajakumar G, Zhang YQ, Simpkins CE, Greenwald D, Yu CJ, Bodor N, Day AL: Estrogens may reduce mortality and ischemic damage caused by middle cerebral artery occlusion in the female rat. J Neurosurg 1997; 87: 724-730.
60. Alkayed NJ, Harukuni I, Kimes AS, London ED, Traystman RJ, Hurn PD: Gender-linked brain injury in experimental stroke. Stroke 1998; 29: 159-166.
61. Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM: Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 1998; 18: 1253-1258.
62. Hurn PD, Macrae IM: Estrogen as a neuroprotectant in stroke. J Cereb Blood Flow Metab 2000; 20: 631-652.
63. McCullough LD, Alkayed NJ, Traystman RJ, Williams MJ, Hurn PD: Postischemic estrogen reduces hypoperfusion and secondary ischemia after experimental stroke. Stroke 2001; 32: 796-802.
64. Harman SM, Brinton EA, Cedars M, Lobo R, Manson JE, Merriam GR, Miller VM, Naftolin F, Santoro N: KEEPS: the Kronos Early Estrogen Prevention Study. Climacteric 2005; 8: 3-12.
65. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, Buring JE, Criqui MH, Herrington D, Lynch JK, Rapp SR, Torner J: Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006; 113: 2425-2434.
66. Shumaker SA, Legault C, Rapp SR, Thal L, Wallace RB, Ockene JK, Hendrix SL, Jones BN 3rd, Assaf AR, Jackson RD, Kotchen JM, Wassertheil-Smoller S, Wactawski-Wende J: Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2651-2662.
67. Rapp SR, Espeland MA, Shumaker SA, Henderson VW, Brunner RL, Manson JE, Gass ML, Stefanick ML, Lane DS, Hays J, Johnson KC, Coker LH, Dailey M, Bowen D: Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA 2003; 289: 2663-2672.
68. Shumaker SA, Legault C, Kuller L, Rapp SR, Thal L, Lane DS, Fillit H, Stefanick ML, Hendrix SL, Lewis CE, Masaki K, Coker LH: Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2947-2958.
69. Resnick SM, Coker LH, Maki PM, Rapp SR, Espeland MA, Shumaker SA: The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive decline. Clin Trials 2004; 1: 440-450.
70. Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J: Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA 2004; 291: 2959-2968.
71. O'Collins VE, Macleod MR, Donnan GA, Horky LL, van der Worp BH, Howells DW: 1,026 experimental treatments in acute stroke. Ann Neurol 2006; 59: 467-477.
72. Alkayed NJ, Murphy SJ, Traystman RJ, Hurn PD, Miller VM: Neuroprotective effects of female gonadal steroids in reproductively senescent female rats. Stroke 2000; 31: 161-168.
73. Dubal DB, Wise PM: Neuroprotective effects of estradiol in middle-aged female rats. Endocrinology 2001; 142: 43-48.
74. Toung TJ, Traystman RJ, Hurn PD: Estrogen-mediated neuroprotection after experimental stroke in male rats. Stroke 1998; 29: 1666-1670.
75. Suzuki S, Brown CM, Dela Cruz CD, Yang E, Bridwell DA, Wise PM: Timing of estrogen therapy after ovariectomy dictates the efficacy of its neuroprotective and antiinflammatory actions. Proc Natl Acad Sci USA 2007; 104: 6013-6018.
76. Bogousslavsky J, Pierre P: Ischemic stroke in patients under age 45. Neurol Clin 1992; 10: 113-124.
77. Bushnell CD: Stroke and the female brain. Nat Clin Pract Neurol 2008; 4: 22-33.
78. Spencer SJ, Galic MA, Tsutsui M, Pittman QJ, Mouihate A: Effects of global cerebral ischemia in the pregnant rat. Stroke 2008; 39: 975-982.
79. Kittner SJ, Stern BJ, Feeser BR, Hebel R, Nagey DA, Buchholz DW, Earley CJ, Johnson CJ, Macko RF, Sloan MA, Wityk RJ, Wozniak MA: Pregnancy and the risk of stroke. N Engl J Med 1996; 335: 768-774.
80. Salonen Ros H, Lichtenstein P, Bellocco R, Petersson G, Cnattingius S: Increased risks of circulatory diseases in late pregnancy and puerperium. Epidemiology 2001; 12: 456-460.
81. James AH, Bushnell CD, Jamison MG, Myers ER: Incidence and risk factors for stroke in pregnancy and the puerperium. Obstet Gynecol 2005; 106: 509-516.
82. Bashiri A, Lazer T, Burstein E, Smolin A, Lazer S, Perry ZH, Mazor M: Maternal and neonatal outcome following cerebrovascular accidents during pregnancy. J Matern Fetal Neonatal Med 2007; 20: 241-247.
83. Sharshar T, Lamy C, Mas JL: Incidence and causes of strokes associated with pregnancy and puerperium. A study in public hospitals of Ile de France. Stroke in Pregnancy Study Group. Stroke 1995; 26: 930-936.
84. Cipolla MJ, Vitullo L, Delance N, Hammer E: The cerebral endothelium during pregnancy: a potential role in the development of eclampsia. Endothelium 2005; 12: 5-9.
85. Mendelsohn ME, Karas RH: The protective effects of estrogen on the cardiovascular system. N Engl J Med 1999; 340: 1801-1811.
86. Miller AP, Feng W, Xing D, Weathington NM, Blalock JE, Chen YF, Oparil S: Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation 2004; 110: 1664-1669.
87. Orshal JM, Khalil RA: Gender, sex hormones, and vascular tone. Am J Physiol Regul Integr Comp Physiol 2004; 286:R233-R249.
88. Pelligrino DA, Galea E: Estrogen and cerebrovascular physiology and pathophysiology. Jpn J Pharmacol 2001; 86: 137-158.
89. Krause DN, Duckles SP, Pelligrino DA: Influence of sex steroid hormones on cerebrovascular function. J Appl Physiol 2006; 101: 1252-1261.
90. Harman SM, Naftolin F, Brinton EA, Judelson DR: Is the estrogen controversy over? Deconstructing the Women's Health Initiative Study: a critical evaluation of the evidence. Ann NY Acad Sci 2005; 1052: 43-56.
91. Bath PM, Gray LJ: Association between hormone replacement therapy and subsequent stroke: a meta-analysis. BMJ 2005; 330: 342.
92. Mikkola TS, Anthony MS, Clarkson TB, St Clair RW: Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens. Metabolism 2002; 51: 523-530.
93. Dan P, Cheung JC, Scriven DR, Moore ED: Epitope-dependent localization of estrogen receptor-alpha, but not -beta, in en face arterial terial endothelium. Am J Physiol Heart Circ Physiol 2003; 284:H1295-H1306.
94. Stirone C, Duckles SP, Krause DN: Multiple forms of estrogen receptor-alpha in cerebral blood vessels: regulation by estrogen. Am J Physiol Endocrinol Metab 2003; 284: E184-E192.
95. Stirone C, Boroujerdi A, Duckles SP, Krause DN: Estrogen receptor activation of phosphoinositide-3 kinase, akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol 2005; 67: 105-113.
96. Stirone C, Chu Y, Sunday L, Duckles SP, Krause DN: 17 Beta-estradiol increases endothelial nitric oxide synthase mRNA copy number in cerebral blood vessels: quantification by real-time polymerase chain reaction. Eur J Pharmacol 2003; 478: 35-38.
97. Sudhir K, Chou TM, Chatterjee K, Smith EP, Williams TC, Kane JP, Malloy MJ, Korach KS, Rubanyi GM: Premature coronary artery disease associated with a disruptive mutation in the estrogen receptor gene in a man. Circulation 1997; 96: 3774-3777.
98. Zhang Y, Xie R, Wang Y, Chen D, Wang G, Xu X: Association of estrogen receptor gene polymorphism with cerebral infarction, a case-control study. Zhonghua Yi Xue Za Zhi 2002; 82: 1443-1446.
99. Shearman AM, Cooper JA, Kotwinski PJ, Humphries SE, Mendelsohn ME, Housman DE, Miller GJ: Estrogen receptor alpha gene variation and the risk of stroke. Stroke 2005; 36: 2281-2282.
100. Molvarec A, Szeplaki G, Kovacs M, Szeplaki Z, Fazakas A, Prohaszka Z, Fust G, Karadi I: Estrogen receptor alpha (ESR1) PvuII and XbaI gene polymorphisms in ischemic stroke in a Hungarian population. Clin Chim Acta 2007; 382: 100-105.
101. Lehtimaki T, Kunnas TA, Mattila KM, Perola M, Penttila A, Koivula T, Karhunen PJ: Coronary artery wall atherosclerosis in relation to the estrogen receptor 1 gene polymorphism: an autopsy study. J Mol Med 2002; 80: 176-180.
102. Lu H, Higashikata T, Inazu A, Nohara A, Yu W, Shimizu M, Mabuchi H: Association of estrogen receptor-alpha gene polymorphisms with coronary artery disease in patients with familial hypercholesterolemia. Arterioscler Thromb Vasc Biol 2002; 22: 817-823.
103. Shearman AM, Cupples LA, Demissie S, Peter I, Schmid CH, Karas RH, Mendelsohn ME, Housman DE, Levy D: Association between estrogen receptor alpha gene variation and cardiovascular disease. JAMA 2003; 290: 2263-2270.
104. Kjaergaard AD, Ellervik C, Tybjaerg-Hansen A, Axelsson CK, Gronholdt ML, Grande P, Jensen GB, Nordestgaard BG: Estrogen receptor alpha polymorphism and risk of cardiovascular disease, cancer, and hip fracture: cross-sectional, cohort, and casecontrol studies and a meta-analysis. Circulation 2007; 115: 861-871.
105. Schuit SC, Oei HH, Witteman JC, Geurts van Kessel CH, van Meurs JB, Nijhuis RL, van Leeuwen JP, de Jong FH, Zillikens MC, Hofman A, Pols HA, Uitterlinden AG: Estrogen receptor alpha gene polymorphisms and risk of myocardial infarction. JAMA 2004; 291: 2969-2977.
106. Matsubara Y, Murata M, Kawano K, Zama T, Aoki N, Yoshino H, Watanabe G, Ishikawa K, Ikeda Y: Genotype distribution of estrogen receptor polymorphisms in men and postmenopausal women from healthy and coronary populations and its relation to serum lipid levels. Arterioscler Thromb Vasc Biol 1997; 17: 3006-3012.
107. Koch W, Hoppmann P, Pfeufer A, Mueller JC, Schomig A, Kastrati A: No replication of association between estrogen receptor alpha gene polymorphisms and susceptibility to myocardial infarction in a large sample of patients of European descent. Circulation 2005; 112: 2138-2142.
108. Rexrode KM, Ridker PM, Hegener HH, Buring JE, Manson JE, Zee RY: Polymorphisms and haplotypes of the estrogen receptor-beta gene (ESR2) and cardiovascular disease in men and women. Clin Chem 2007; 53: 1749-1756.
109. Du L, Bayir H, Lay Y, Zhang X, Kochanek PM, Watkins SC, Graham SH, Clark RS: Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 2004;279:38563-38570.
110. Li H, Pin S, Zeng Z, Wang MM, Andreasson KA, McCullough LD: Sex differences in cell death. Ann Neurol 2005; 58: 317-321.
111. McCullough LD, Zeng Z, Blizzard KK, Debchoudhury I, Hurn PD: Ischemic nitric oxide and poly (ADP-ribose) polymerase-1 in cerebral ischemia: male toxicity, female protection. J Cereb Blood Flow Metab 2005; 25: 502-512.
112. Johnston MV, Hagberg H: Sex and the pathogenesis of cerebral palsy. Dev Med Child Neurol 2007; 49: 74-78.
113. Jarvis S, Glinianaia SV, Arnaud C, Fauconnier J, Johnson A, McManus V, Topp M, Uvebrant P, Cans C, Krageloh-Mann I: Case gender and severity in cerebral palsy varies with intrauterine growth. Arch Dis Child 2005; 90: 474-479.
114. Ingemarsson I: Gender aspects of preterm birth. BJOG 2003; 110(suppl 20):34-38.
115. Hintz SR, Kendrick DE, Vohr BR, Kenneth Poole W, Higgins RD, for The Nichd Neonatal Research Network: Gender differences in neurodevelopmental outcomes among extremely preterm, extremely-low-birthweight infants. Acta Paediatr 2006; 95: 1239-1248.
116. Sheiner E, Levy A, Katz M, Hershkovitz R, Leron E, Mazor M: Gender does matter in perinatal medicine. Fetal Diagn Ther 2004; 19: 366-369.
117. Di Renzo GC, Rosati A, Sarti RD, Cruciani L, Cutuli AM: Does fetal sex affect pregnancy outcome? Gend Med 2007; 4: 19-30.
118. Zhu C, Xu F, Wang X, Shibata M, Uchiyama Y, Blomgren K, Hagberg H: Different apoptotic mechanisms are activated in male and female brains after neonatal hypoxia-ischaemia. J Neurochem 2006; 96: 1016-1027.
119. Hurn PD, Vannucci SJ, Hagberg H: Adult or perinatal brain injury: does sex matter? Stroke 2005; 36: 193-195.
120. Bona E, Hagberg H, Loberg EM, Bagenholm R, Thoresen M: Protective effects of moderate hypothermia after neonatal hypoxia-ischemia: short- and long-term outcome. Pediatr Res 1998; 43: 738-745.
121. Hagberg H, Wilson MA, Matsushita H, Zhu C, Lange M, Gustavsson M, Poitras MF, Dawson TM, Dawson VL, Northington F, Johnston MV: Parp-1 gene disruption in mice preferentially protects males from perinatal brain injury. J Neurochem 2004; 90: 1068-1075.
122. Nijboer CH, Groenendaal F, Kavelaars A, Hagberg HH, van Bel F, Heijnen CJ: Gender-specific neuroprotection by 2-iminobiotin after hypoxia-ischemia in the neonatal rat via a nitric oxide independent pathway. J Cereb Blood Flow Metab 2007; 27: 282-292.
123. Renolleau S, Fau S, Goyenvalle C, Joly LM, Chauvier D, Jacotot E, Mariani J, Charriaut-Marlangue C: Specific caspase inhibitor Q-VD-OPh prevents neonatal stroke in P7 rat: a role for gender. J Neurochem 2007; 100: 1062-1071.
124. Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, Hendrix S, Howard BV, Hsia J, Hubbell A, Jackson R, Johnson KC, Judd H, Kotchen JM, Kuller L, LaCroix AZ, Lane D, Langer RD, Lasser N, Lewis CE, Manson J, Margolis K, Ockene J, O'Sullivan MJ, Phillips L, Prentice RL, Ritenbaugh C, Robbins J, Rossouw JE, Sarto G, Stefanick ML, Van Horn L, Wactawski-Wende J, Wallace R, Wassertheil-Smoller S: Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA 2004; 291: 1701-1712.